EndoQuest Robotics and Omnivision have unveiled their collaboration to integrate Omnivision’s image sensor technology into surgical robotics systems.
Specializing in semiconductor innovations, Omnivision delivers cutting-edge digital imaging and touch technology. Their CameraCubeChip is set to be incorporated into EndoQuest’s flexible robotic platform designed for surgical applications.
Situated in Houston, EndoQuest has engineered a system to fulfill previously unmet demands in gastrointestinal and endoluminal surgeries. The design aims to enhance precision and adaptability, ultimately boosting patient outcomes. This groundbreaking technology facilitates navigation and procedures within luminal spaces of the body for minimally invasive procedures.
EndoQuest’s platform allows therapeutic endoscopists and surgeons to perform operations via trans-oral or trans-anal methods. Just last month, EndoQuest secured $42 million in funding to bolster the platform’s development. Additionally, the FDA’s Safer Technologies Program (STeP) has recently welcomed this flexible surgical robotic system.
Omnivision’s CameraCubeChip uniquely offers a visualization solution employing PureCel Plus-S pixel technology. The result is high full-well capacity, no image blooming, and reduced power consumption, all while delivering sharp, clear, and lifelike visuals. This compact, medical-grade solution is projected to elevate patient care and surgical visualization.
Kurt Azarbarzin, CEO of EndoQuest Robotics, said, “We are thrilled to incorporate Omnivision’s industry-leading sensor technology into our visualization suite for our pioneering platform. It’s crucial to have advanced imaging to enhance physician capabilities, notably within the restricted space of the gastrointestinal (GI) tract. Omnivision’s latest technology is perfectly suited to our flexible robotic system.”